The human triple negative breast cancer (TNBC) MDA-MB-231 and MDA-MB-468 cells, with higher levels of c-Met expression, are the most sensitive to the antiproliferative effects of HVS compared to other breast cancer cells with lower c-Met levels. This evidence concerns the gene MET and breast carcinoma.